An overview of the pharmacogenetics and molecular genetics of ADHD

Current Pharmacogenomics

Volumn 4, Issue 3, 2006, Pages 231-243

  Lowe, Naomi ^a   Barry, Edwina ^a   Gill, Michael ^a   Hawi, Ziarih ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Dopaminergic; Genetic association; Methylphenidate; Pharmacogenetic; Serotonergic and noradrenergic systems

Indexed keywords

5 HYDROXYTRYPTOPHAN; ATOMOXETINE; CATECHOLAMINE; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE TRANSPORTER; FENFLURAMINE; FLUOXETINE; METHYLPHENIDATE; NORADRENALIN; NORADRENALIN TRANSPORTER; PLACEBO; QUIPAZINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRYPTOPHAN;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; DRUG RESPONSE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MOLECULAR GENETICS; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOGENETICS; REVIEW; SEROTONINERGIC TRANSMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANIMALIA;

EID: 33748674646     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016006778195106     Document Type: Review

References (135)

1. Amara, S. and Kuhar, M. (1993) Neurotransmitter transporters: recent progress. Ann. Rev. Neurosci. 16, 73-93.
2. Ashgari, V.; Sanyal, S.; Buchwaldt, S. (1995) Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem. 65, 1157-1165.
3. Bakker, S. C.; van der Meulen, E. M.; Oteman, N.; Schelleman, H.; Pearson, P. L.; Buitelaar, J. K. and Sinke, R. J. (2005) DATI, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 132, 50-52.
4. Barkley, R. A. (2002) Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 63, 10-15.
5. Barr, C. L.; Feng, Y.; Wigg, K.; Bloom, S.; Roberts, W.; Malone, M.; Schachar, R.; Tannock, R. and Kennedy, J. L. (2000a) Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol. Psychiatry 5, 405-409.
6. Barr, C. L.; Wigg, K.; Malone, M.; Schachar, R.; Tannock, R; Roberts, W. and Kennedy, J. L. (1999) Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am. J. Med. Genet. (Neuropsychiatr Genet.) 88, 710-713.
7. Barr, C. L.; Wigg, K.; Zai, G.; Roberts, W.; Malone, M.; Schachar, R.; Tannock, R. and Kennedy, J. L. (2001) Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C. Mol. Psychiatry 6, 334-347.
8. Barr, C. L.; Xu, C.; Kroft J.; Feng, Y.; Wigg, K.; Zai, G.; Tannock, R.; Schachar, R.; Malone, M.; Roberts, W.; Nothen, M. M.; Grunhage, F.; Vandenbergh, D. J.; Uhl, G.; Sunohara, G.; King, N. and Kennedy, J. L. (2001) Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol. Psychiatry. 49, 333-339.
9. Barr, C. L.; Wigg, K. G.; Wu, J.; Zai, C.; Bloom, S.; Tannock, R.; Roberts, W.; Malone, M.; Schachar, R. and Kennedy, J. L.(2000) Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96(1), 114-117.
10. Barry, E. and Gill, M. (2006) Environmental risk factors and gene-environment interaction in ADHD. In Handbook of ADHD; Gill, M.; Bellgrove, M.; Fitzgerald, M.; Eds.; John Wiley and Sons Ltd. (in press).
11. Beitchman, J. H.; Davidge, K. M.; Kennedy, J. L.; Atkinson, L.; Lee, V.; Shapiro, S. and Douglas, L. (2003) The serotonin transporter gene in aggressive children with and without ADHD and nonaggressive matched controls. Ann. N. Y. Acad. Sci. 1008, 248-251.
12. Ben Amor, L.; Grizenko, N.; Schwartz, G.; Ter-Stepanian, N.; Torkman-Zehi, A.; Sengputa, S.; Lageix, P.; Baron, C.; Mbekou, V. and Joober, R. (2004) Association between three polymorphisms in the dopamine receptor D4 (DRD4) gene and attention deficit hyperactivity disorder (ADHD): a pharmacogenetic study. Proceedings of the XIIth World Congress of Psychiatric Genetics, Dublin, Ireland, 2004.
13. Bhaduri, N.; Sinha, S.; Chattopadhyay, A.; Gangopadhyay, P. K.; Singh, M. and Mukhopadhyay, K. K. (2005) Analysis of polymorphisms in the dopamine Beta hydroxylase gene: association with attention deficit hyperactivity disorder in Indian children. Indian. Pediatr. 42, 123-129.
14. Biederman, J. and Spencer, T. (2000) Non-stimulant treatments for ADHD. Eur. Child. Adolesc. Psychiatry 9, 51-59.
15. Bobb, A. J.; Addington, A. M.; Sidransky, E.; Gornick, M. C.; Lerch, J. P.; Greenstein, D. K.; Clasen, L. S.; Sharp, W. S.; Inoff-Germain, G.; Wavrant-De Vrieze, F.; Arcos-Burgos, M.; Straub, R. E.; Hardy, J. A.; Castellanos, F. X. and Rapoport, J. L. (2005) Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 134, 67-72.
16. Brophy, K.; Hawi, Z.; Kirley, A.; Fitzgerald, M. and Gill, M. (2002) Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol. Psychiatry 7, 913-917.
17. Carrasco, X.; Rothhammer, P.; Moraga, M.; Henriquez, H.; Aboitiz, F. and Rothhammer, F. Presence of DRD4/7R and DATI/10R allele in Chilean family members with attention deficit hyperactivity disorder. Rev. Med. Chil. 132, 1047-1052.
18. Castellanos, F. X.; Lau, E.; Tayebi, N.; Lee, P.; Long, R. E.; Giedd, J. N.; Sharp, W.; Marsh, W. L.; Walter, J. M.; Hamburger, S. D.; Ginns, E. I.; Rapoport, J. L. and Sidransky, E. (1998) Lack of an association between a dopamine-4 receptor polymorphism and attention deficit/ hyperactivity disorder: genetic and brain morphometric analyses. Mol. Psychiatry 3, 431-434.
19. Chen, C. K.; Chen, S. L.; Mill, J.; Huang, Y. S.; Lin, S. K.; Curran, S.; Purcell, S.; Sham, P. and Asherson, P. (2003) The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol. Psychiatry 8, 393-396.
20. Cheon, K.-A.; Ryu, Y.-H.; Kim, J.-W.; and Cho, D.-Y. (2005) The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methyl-phenidate. Eur. Neuropsychopharmacol. 15(1), 95-101.
21. Coleman, M. (1971) Serotonin concentrations in whole blood of hyperactive children. J. Pediatr. 78, 985-990.
22. Comings, D. E.; Comings, B. G.; Muhleman, D.; Dietz, G.; Shahbahrami, B.; Tast, D.; Knell, E.; Kocsis, P.; Baumgarten, R. and Kovacs, B. W. (1991) The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266, 1793-1800.
23. Comings, D. E.; Gade-Andavolu, R.; Gonzalez, N.; Blake, H.; Wu, S. and MacMurray, J. P. (1999) Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin. Genet. 55, 160-172.
24. Comings, D. E.; Gade-Andavolu, R.; Gonzalez, N.; Wu, S.; Muhleman, D.; Blake, H.; Dietz, G.; Saucier, G. and MacMurray, J. P. (2000) Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 2O genes. Clin. Genet. 57, 178-196.
25. Comings, D. E.; Gade, R.; Muhleman, D. and Sverd, J. (1995) No association of a tyrosine hydroxylase gene tetranucleotide repeat polymorphism in autism, Tourette syndrome, or ADHD. Biol. Psychiatry 37(7):484-6.
26. Comings, D. E.; Wu, S.; Chiu, C.; Ring, R. H.; Gade, R.; Ahn, C.; MacMurray, J. P.; Dietz, G, and Muhleman, D. (1996) Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes-DRD2, D beta H, and DAT1. Am. J. Med Genet. (Neuropsychiatr. Genet.). 67, 264-288.
27. Cook, E. H. Jr.; Stein, M. A.; Krasowski, M. D.; Cox, N. J.; Olkon, D. M.; Kieffer, J. E. and Leventhal, B. L. (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Gene. (Neuropsychiatr. Genet.) 56, 993-998.
28. Cornish, K. M.; Manly, T.; Savage, R.; Swanson, J.; Morisano, D.; Butler, N.; Grant, C.; Cross, G.; Bentley, L. and Hollis, C. P. (2005) Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol. Psychiatry 10, 686-698.
29. Curran, S.; Mill, J.; Tahir, E.; Kent, L.; Richards, S.; Gould, A.; Huckett L.; Sharp, J.; Batten, C.; Fernando, S.; Ozbay, F.; Yazgan, Y.; Simonoff, E.; Thompson, M.; Taylor, E. and Asherson, P. (2001) Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol. Psychiatry 6, 425-428.
30. Curran, S.; Purcell, S.; Craig, I.; Asherson, P. and Sham, P. (2005) The scrotonin transporter gene as a QTL for ADHD. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 134, 42-47.
31. Daly, G.; Hawi, Z.; Fitzgerald, M. and Gill, M. (1999) Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1; DBH and DRD5 to affected children. Mol. Psychiatry 4, 192-196.
32. Davids, E.; Zhang, K.; Tarazi, F. I. and Baldessarini, R. J. (2003) Animal models of attention-deficit hyperactivity disorder. Brain. Res. Brain. Res. Rev. 42, 1-21.
33. De Luca, V.; Muglia, P.; Vincent J. B.; Lanktree, M.; Jain, U. and Kennedy, J. L. (2004) Adrenergic alpha 2C receptor genomic organization: association study in adult ADHD. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 127, 65-67.
34. Domschke, K.; Sheehan, K.; Lowe, N.; Kirley, A.; Mullins, C.; O'Sullivan, R.; Freitag, C.; Becker, T.; Conroy, J.; Fitzgerald, M.; Gill, M. and Hawi, Z. (2005) Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 134, 110-114.
35. Eisenberg, J.; Mei-Tal, G.; Steinberg, A.; Tartakovsky, E.; Zohar, A.; Gritsenko, I.; Nemanov, L. and Ebstein, R. P. (1999) Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am. J. Med. Genet.(Neuropsychiatr. Genet.) 88, 497-502.
36. Elia, J.; Borcherding, B. G.; Rapoport, J. L. and Kaysor, C. S. (1991) Mediylphenidate and dextroamphetamine treatments of hyperactivity: Are there true non-responders? Psychiatry Res. 36, 141-155.
37. Faraone, S. V.; Doyle, A. E.; Mick, E. and Biederman, J. (2001) Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry 158, 1052-1057.
38. Faraone, S. V.; Perlis, R. H.; Doyle, A. E.; Smoller, J. W.; Goralnick, J. J.; Holmgren, M. A. and Sklar, P. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 1313-1323.
39. Faraone, S. V.; Sergeant, J.; Gillberg, C. and Biederman, J. (2003) The Worldwide Prevalence of ADHD: Is it an American Condition? World Psych. 2, 104-113.
40. Gainetdinov, R. R.; Gromov, A. I. and Kudrin, V. S. (1991) The extracellular content of dopamine, its metabolites and 5-hydroxyindoleacetic acid in the amygdala of free-moving rats during an act of interspecific aggression. Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova. 41, 584-586.
41. Gainetdinov, R. R.; Wetsel, W. C.; Jones, S. R.; Levin, E. D.; Jaber, M. and Caron, M. G. (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397-401.
42. Gill, M.; Daly, G.; Heron, S.; Hawi, Z. and Fitzgerald, M. (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol. Psychiatry 2, 311-313.
43. Gillberg, C.; Gillberg, I. C.; Rasmussen, P.; Kadesjo, B.; Soderstrom, H.; Rastam, M.; Johnson, M.; Rothenberger, A. and Niklasson, L. (2004) Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur. Child. Adolesc. Psychiatry 13(Suppl. 1), 180-192.
44. Greenhill, L. L.; Halperin, J. M. and Abikoff, H. (1999) Stimulant Medications. J. Am. Acad. Child. Adolesc. Psychiatry 38(5), 503-512.
45. Gregory-Evans, C. Y.; Williams, M. J.; Halford, S.; Gregory-Evans, K. (2004) Ocular coloboma: a reassessment in the age of molecular neuroscience. J. Med. Genet. 41, 881-891.
46. Hamarman, S.; Fossella, J.; Ulger, C.; Brimacombe, M. and Dermody, J. (2004) Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study. J. Child. Adolesc. Psychopharmacol. 14(4), 564-574.
47. Hawi, Z.; Dring, M.; Kirley, A.; Foley, D.; Kent, L.; Craddock, N.; Asherson, P.; Curran, S.; Gould, A.; Richards, S.; Lawson, D.; Pay, H.; Turic, D.; Langley, K.; Owen, M.; O'Donovan, M.; Thapar, A.; Fitzgerald, M. and Gill, M. (2002) Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT (1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol. Psychiatry 7(7), 718-725.
48. Hawi, Z.; Lowe, N.; Kirley, A.; Gruenhage, F.; Nothen, M.; Greenwood, T.; Kelsoe, J., Fitzgerald, M. and Gill, M. (2003) Linkage disequilibrium mapping at DATI, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol. Psychiatry 8, 299-308.
49. Hawi, Z.; Lowe, N.; Kirley, A.; Gruenhage, F.; Nothen, M.; Greenwood, T.; Kelsoe, J.; Fitzgerald, M. and Gill, M. (2003) Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol. Psychiatry 8, 299-308.
50. Hawi, Z.; McCarron, M.; Kirley, A.; Daly, G.; Fitzgerald, M. and Gill, M. (2000a) No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96, 268-272.
51. Hawi, Z.; Millar, N.; Daly, G.; Fitzgerald, M. and Gill, M. (2000b) No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96, 282-284.
52. Hechtman, L. and Weiss, G. (1986) Controlled prospective fifteen-year follow-up of hyperactives as adults: non-medical drug and alcohol use and anti-social behaviour; Can. J. Psych. 31, 557-567.
53. Heils, A.; Teufel, A,; Petri, S.; Stober, G.; Riederer, P.; Bengel, D. and Lesch, K. P. (1996) Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621-2624.
54. Holmes, J.; Payton, A.; Barrett, J. H.; Hever, T.; Fitzpatrick, H.; Trumper, A. L.; Harrington, R.; McGuffin, P.; Owen, M.; Ollier, W.; Worthington, J. and Thapar, A. (2000) A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol. Psychiatry 5, 523-530.
55. Hotamisligil, G. S. and Breakefield, X. O. (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am. J. Hum. Genet. (Neuropsychiatr, Genet.) 49, 383-392.
56. Huang, Y. S.; Lin, S. K.; Wu, Y. Y.; Chao, C. C. and Chen, C. K. (2003) A family-based association study of attention-deficit hyperactivity disorder and dopamine D2 receptor TaqI A alleles. Chang. Gung. Med. J. 26, 897-903.
57. Inkster, B.; Muglia, P.; Jain, U. and Kennedy, J. L. (2004) Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder. Psychiatr. Genet. 14, 117-120.
58. Kent, L.; Doerry, U.; Hardy, E.; Parmar, R.; Gingell, K.; Hawi, Z.; Kirley, A.; Lowe, N.; Fitzgerald, M.; Gill, M. and Craddock, N. (2002) Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol. Psychiatry 7(8), 908-912.
59. Kim, Y. S.; Leventhal, B. L.; Kim, S. J.; Kim, B. N.; Cheon, K. A.; Yoo, H. J.; Kim, S. J.; Badner, J. and Cook, E. H. (2005b) Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Neurosci. Lett. [Epub ahead of print].
60. Kirley, A.; Hawi, Z.; Daly, G.; McCarron, M.; Mullins, C.; Millar, N.; Waldman, I.; Fitzgerald, M. and Gill, M. (2002) Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27, 607-619.
61. Kirley, A.; Lowe, N.; Hawi, Z.; Mullins, C.; Daly, G.; Waldman, I; Fitzgerald, M. and Gill, M. (2003) Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 121, 50-54.
62. Klein, R. G. and Mannuzza, S. (1991) Long-term outcome of hyperactive children: a review. J. Am. Acad. Child. Adolesc. Psychiatry 30, 383-387.
63. Kustanovich, V.; Ishii, J., Crawford, L.; Yang, M.; McGough, J. J.; McCracken, J. T.; Smalley, S. L. and Nelson, S. F.(2004) Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol. Psychiatry 9, 711-717.
64. Kustanovich, V.; Merriman, B.; McGough, J.; McCracken, J. T.; Smalley, S. L. and Nelson, S. F. (2003) Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol. Psychiatry 8, 309-315.
65. LaHoste, G. J.; Swanson, J. M.; Wigal, S. B.; Glabe, C.; Wigal, T.; King, N. and Kennedy, J. L. (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry 1, 121-124.
66. Langley, K.; Turic, D.; Peirce, T. R.; Mills, S.; Van Den Bree, M. B., Owen, M. J.; O'Donovan, M. C. and Thapar, A. (2005) No support for association between the dopamine transporter (DAT1) gene and ADHD. Am. J. Med. Genet. (Neuropsychiatr. Genet.) Aug 4, [Epub ahead of print].
67. Lawson, D. C.; Turic, D.; Langley, K.; Pay, H. M.; Govan, C. F.; Norton, N.; Hamshere, M. L.; Owen, M. J.; O'Donovan, M. C. and Thapar, A. (2003) Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 116(1), 84-89.
68. Levitan, R. D.; Masellis, M.; Basile, V. S.; Lam, R. W.; Jain, U.; Kaplan, A. S.; Kennedy, S. H.; Siegel, G.; Walker, M. L.; Vaccarino, F. J. and Kennedy, J. L. (2002) Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. J. Affect Disord. 71, 229-233.
69. Levy, F. and Swanson, J. M. (2001) Timing; space and ADHD: the dopamine theory revisited. Aust. N. Z. J. Psych. 35(4), 504-511.
70. Li, J.; Wang, Y. F.; Zhou, R. L.; Yang, L.; Zhaing, H. B. and Wang, B. (2003) Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder with or without learning disorder. Zhonghua. Yi. Xue. Za. Zhi. 83, 2114-2118.
71. Li, J.; Wang, Y.; Qian, Q.; Wang, B. and Zhou, R. (2002) Association of 5-HT(2A) receptor polymorphism and attention deficit hyperactivity disorder in children. Zhonghua. Yi. Xue. Za Zhi. 82, 1173-1176.
72. Li, J.; Wang, Y.; Zhou, R.; Zhang, H.; Yang, L.; Wang, B.; Khan, S. and Faraone, S. V. (2005) Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 132(1), 59-63.
73. Lowe, N.; Kirley, A.; Hawi, Z.; Sham, P.; Wickham, H.; Kratochvil, C. J.; Smith, S. D.; Lee, S. Y.; Levy, F.; Kent, L.; Middle, F.; Rohde, L. A.; Roman, T.; Tahir, E.; Yazgan, Y.; Asherson, P.; Mill J.; Thapar, A.; Payton, A.; Todd, R. D.; Stephens, T.; Ebstein, R. P.; Manor, I.; Barr, C. L.; Wigg, K. G.; Sinke, R. J.; Buitelaar, J. K.; Smalley, S. L.; Nelson, S. F.; Biederman, J.; Faraone, S. V. and Gill, M. (2004) Joint analysis of the DRD5 marker concludes association with attention deficit/ hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am. J. Hum. Genet. 74(2), 348-356.
74. Lowe, N.; Kirley, A.; Mullins, C.; Fitzgerald, M.; Gill, M. and Hawi, Z. (2004) Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with the SNP-616. Am. J. Med. Genet (Neuropsychiatr. Genet.) 131(1), 33-37.
75. Maher, B. S.; Marazita, M. L.; Ferrell, R. E. and Vanyukov, M. M. (2002) Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr. Genet. 12(4), 207-215.
76. Mannuzza, S.; Klein, R. G.; Bessler, A.; Malloy, P. and LaPadula, M. (1993) Adult outcome of hyperactive boys, Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 50, 565-576.
77. Manor, I.; Corbex, M.; Eisenberg, J.; Gritsenkso, I.; Bachner-Melman, R.; Tyano, S. and Ebstein, R. P. (2004) Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am. J. Med. Genet. (Neuropsychiatr. Genet.) 127, 73-77.
78. Manor, I.; Eisenberg, J.; Tyano, S.; Sever, Y.; Cohen, H.; Ebstein, R. P. and Kotler, M. (2001) Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 105, 91-95.
79. Manor, I.; Kotler, M.; Sever, Y.; Eisenberg, J.; Cohen, H.; Ebstein, R. P.; Tyano, S. (2000) Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second; independently recruited Israeli cohort. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96, 858-860.
80. Manor, I.; Tyano, S.; Mel, E.; Eisenberg, J., Bachner-Melman, R.; Kotler, M. and Ebstein, R. P. (2002) Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol. Psychiatry 7, 626-632.
81. Manuck, S. B.; Flory, J. D.; Ferrell, R. E.; Mann, J. J.; Muldoon, M. F.(2000) A regulatory polymorphism of the monoamine oxidase - A gene may be associated with variabillity aggresion, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 95(1), 9-23.
82. McCracken, J. T.; Smalley, S. L.; McGough, J. J.; Crawford, L.; Del'Homme, M.; Cantor, R. M.; Liu, A. and Nelson, S. F.(2000) Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol. Psychiatry 5, 531-536.
83. McEvoy, B.; Hawi, Z.; Fitzgerald, M. and Gill, M. (2002) No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 114, 665-666.
84. Michelson, D.; Adler, L.; Spencer, T.; Reimberr, F. W.; West, S. A.; Allen, A. J.; Kelsey, D.; Wernicke, J.; Dietrich, A. and Milton, D. (2003) Atomoxetine in adults with ADHD: two randomised, placebo-controlled studies. Biol. Psych. 53, 112-120.
85. Michelson, D.; Faries, D.; Wernicke, J.; Kelsey, D.; Kendrick K.; Sallee, F. R. and Spencer, T. (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomised, placebo-controlled, dose-response study. Pediatrics 108, E83.
86. Mill, J.; Curran, S.; Kent, L.; Gould, A.; Huckett, L.; Richards, S.; Taylor, F. and Asherson, P. (2002) Association study of a SNAP-25 micro-satellite and attention deficit hyperactivity disorder. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 114, 269-271.
87. Mill, J.; Fisher, N.; Curran, S.; Richards, S.; Taylor, E. and Asherson, P. (2003) Polymorphisms in the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Neuroreport 14, 1463-1456.
88. Mill, J.; Richards, S.; Knight, J.; Curran, S.; Taylor, E. and Asherson, P. (2004b) Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol. Psychiatry 9, 801-810.
89. Mill', J.; Xu, X.; Ronald, A.; Curran, S.; Price, T.; Knight J.; Craig, I.; Sham, P.; Plomin, R. and Asherson, P. (2005) Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4; DAT1; DRD5; SNAP-25; and 5HT1B. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 133(1),68-73.
90. Misener, V. L.; Luca, P.; Azeke, O.; Crosbie, J.; Waldman, I.; Tannock, R.; Roberts, W.; Malone, M.; Schachar, R.; Ickowicz, A.; Kennedy, J. L. and Barr, C. L. (2004) Linkage of the dopamine receptor DI gene to attention-deficit/hyperactivity disorder. Mol. Psychiatry 9, 500-509.
91. Muglia, P.; Jain, U. and Kennedy, J. L. (2002b) A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Behav. Brain Res. 130, 91-95.
92. Muglia, P.; Jain, U.; Inkster, B. and Kennedy, J. L. (2002) A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD. Neuropsychopharmacol. 27(4), 655-662.
93. Muglia, P.; Jain, U.; Macciardi, F. and Kennedy, J. L. (2000) Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am. J. Med. Genet. 96, 273-277.
94. Okuyama, Y.; Ishiguro, H.; Toru, M. and Arinami, T. (1999) A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem. Biophys Res.Commun. 258, 292-295.
95. Palmer, C. G.; Bailey, J. N.; Ramsey, C.; Cantwell, D.; Sinsheimer, J. S.; Del'Homme, M.; McGough, J.; Woodward, J. A.; Asarnow, R.; Asarnow, J.; Nelson, S. and Smalley, S. L. (1999) No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr. Genet. 9, 157-160.
96. Park, L.; Nigg, J. T.; Waldman, I. D.; Nummy, K. A.; Huang-Pollock, C.; Rappley, M. and Friderici, K. H. (2005) Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol. Psychiatry 10, 572-580.
97. Payton, A.; Holmes, J.; Barrett, J. H.; Hever, T., Fitzpatrick, H.; Trumper, A. L.; Harrington, R.; McGuffin, P.; O'Donovan, M.; Owen, M.; Ollier, W.; Worthington, J. and Thapar, A. (2001b) Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 105, 464-470.
98. Payton, A.; Holmes, J.; Barret, J. H.; Sham, P.; Harrington, R.; McGuffin, P., Owen, M,; Ollier, W., Worthington, J. and Thapar, A. (2001a) Susceptibility genes for a trait measure of attention deficit hyperactivity disorder: a pilot study in a non-clinical sample of twins. Psychiatry Res. 105, 273-278.
99. Polanczyk, G.; Zeni, C.; Genro, J. P.; Roman, T.; Hutz, M. H. and Rohde, L. A. (2005) Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. Pharmacogenomics 6(3), 225-234.
100. Purper-Ouakil, D.; Wohl, M.; Mouren, M. C.; Verpillat, P.; Ades, J. and Gorwood, P. (2005) Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr. Genet. 15, 53-59.
101. Qian, Q.; Wang, Y.; Li, J.; Yang, L.; Wang, B. and Zhou, R. (2003a) Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder. Beijing Da. Xue. Xue. Bao. 35, 412-418.
102. Qian, Q.; Wang, Y.; Zhou, R.; Li, J.; Wang, B.; Glatt, S. and Faraone, S. V. (2003b) Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 118, 103-109.
103. Quist J. F.; Barr, C. L.; Schachar, R.; Roberts, W.; Malone, M.; Tannock, R.; Basile, V. S.; Beitchman, J. and Kennedy, J. L. (2000) Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol. Psychiatry 5(5), 537-541.
104. Quist J. F.; Barr, C. L.; Schachar, R.; Roberts, W.; Malone, M.; Tannock, R.; Basile, V. S.; Beitchman, J. and Kennedy, J. L. (2003) The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol. Psychiatry 8(1),98-102.
105. Retz, W.; Retz-Junginger, P.; Hengesch, G.; Schneider, M.; Thome, J.; Pajonk, F. G.; Salahi-Disfan, A.; Rees, O.; Wender, P. H. and Rosler, M. (2004) Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder. Eur. Arch. Psych. Clin. Neurosci. 254, 201-208.
106. Rohde, L. A.; Roman, T.; Szobot, C.; Cunha, R. D.; Hutz, M. H. and Biederman, J. (2003) Dopamine transporter gene, response to methyl-phenidate and cerebral blood flow in attention-deficit/ hyperactivity disorder: a pilot study. Synapse. 48, 87-89.
107. Roman, T.; Schmitz, M.; Polanczyk, G.; Eizirik, M.; Rohde, L. A. and Hutz, M. H. (2001) Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 105, 471-478.
108. Roman, T.; Schmitz, M.; Polanczyk, G. V.; Eizirik, M.; Rohde, L. A.; Hutz, M. H. (2003) Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am. J. Med. Genet. (Neuropsychiatr. Genet.) 120(1), 116-120.
109. Roman, T.; Szobot, C.; Martine, S.; Biederman, J.; Rohde, L. A. and Hutz, M. H. (2002) Dopamine transporter gene and response to methyl-phenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12, 497-499.
110. Rowe, D. C.; Stever, C.; Giedinghagen, L. N.; Gard, J. M.; Cleveland, H. H.; Terris, S. T.; Mohr, J. H.; Sherman, S.; Abramowitz, A. and Waldman, I. D. (1998) Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol. Psychiatry 3, 419-426.
111. Rowe, D. C.; Van den Oord, E. J.; Stever, C.; Giedinghagen, L. N.; Gard, J. M.; Cleveland, H. H.;. Gilson, M.; Terris, S. T.; Mohr, J. H.; Sherman, S.; Abramowitz, A. and Waldman, I. D. (1999) The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol. Psychiatry 4, 580-586.
112. Russell, V. A. (2002) Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav. Brain. Res. 130, 191-196.
113. Russell, V. A.; Allie, S. and Wiggins, T. (2000) Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav. Brain. Res. 117, 69-74.
114. Sabol, S. Z.; Hu, S. and Hamer, D. (1998) A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 103, 273-279.
115. Seeger, G.; Schloss, P. and Schmidt, M. H. (2001) Marker gene polymorphisms in hyperkinetic disorder-predictors of clinical response in treatment with methylphenidate? Neuroscience Lett. 313, 45-48.
116. Sheehan, K.; Lowe, N.; Kirley, A.; Mullins, C.; Fitzgerald, M.; Gill, M. and Hawi, Z. (2005) Tryptophan hydroxlase. 22 (TPH2) gene variants associated with ADHD. Mol. Psychiatry 10, 944-949.
117. Smith, K. M.; Daly, M.; Fischer, M.; Yiannoutsos, C. T.; Bauer, L.; Barkley, R. and Navia, B. A. (2003) Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 119, 77-85.
118. Sollner, T.; Bennett, M. K.; Whiteheart, S. W.; Scheller, R. H. and Rothman, J. E. (1993) A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell. 75, 409-418.
119. Sprich, S.; Biederman, J.; Crawford, M. H.; Mundy, E. and Faraone, S. V. (2000) Adoptive and biological families of children and adolescents with ADHD. J. Am. Acad. Child. Adolesc. Psychiatry 39, 1432-1437.
120. Stein, M. A.; Waldman, I. D.; Sarampote, C. S.; Seymour, K. E.; Robb, A. S.; Conlon, C.; Kim, S. J. and Cook, E. H. (2005) Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacol. 30(7), 1374-1382.
121. Swanson, J. M.; Sunohara, G. A.; Kennedy, J. L.; Regino, R.; Fineberg, E.; Wigal, T.; Lemer, M.; Williams, L.; LaHoste, G. J. and Wigal, S. (1998b) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol. Psychiatry 3, 38-41.
122. Swanson, J. M.; Sergeant, J. A.; Taylor, E.; Sonuga-Barke, E. J.; Jensen, P. S. and Cantwell, D. P. (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351,429-33.
123. Tahir, E.; Curran, S.; Yazgan, Y.; Ozbay, F.; Cirakoglu, B. and Asherson, P. J. (2000a) No association between low- and high-activity catecholamine -methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96, 285-288.
124. Tahir, E.; Yazgan, Y.; Cirakoglu, B.; Ozbay, F.; Waldman, I. and Asherson, P. J. (2000) Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol. Psychiatry 5(4),396-404.
125. Thapar, A.; Holmes, J.; Poulton, K.; Harrington, R. (1999) Genetic basis of attention deficit and hyperactivity. Br. J. Psych. 174, 105-111.
126. Todd, R. D.; Jong, Y. J.; Lobos, E. A.; Reich, W.; Heath, A. C. and Neuman, R. J. (2001) No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 105(8),745-748.
127. Turic, D.; Williams, H.; Langley, K.; Owen, M; Thapar, A. and O'Donovan, M. C. (2005) A family based study of catechol-O-methyltranferase (COMT) and attention deficit hyperactivity disorder (ADHD). Am. J. Med. Genet. (Neupsychiatr. Genet.) 133, 64-67.
128. Waldman, I. D.; Rowe, D. C.; Abramowitz, A.; Kozel, S. T.; Mohr, J. H.; Sherman, S. L.; Cleveland, H. H.; Sanders, M. L.; Gard. J. M. and Stever, C. (1998) Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet, (Neurapsychiatr. Genet.) 63(6), 1767-1776.
129. Wigg, K.; Zai, G.; Schachar, R.; Tannock, R.; Roberts, W.; Malone, M.; Kennedy, J. L. and Barr, C. L. (2002) Attention deficit hyperactivity disorder and the gene for dopamine Beta-hydroxylase. Am. J. Psychiatry 159, 1046-1048.
130. Wilens, T. E.; Biederman, J. and Spencer, T. J. (2002) Attention deficit/ hyperactivity disorder across the lifespan. Ann. Rev. Med. 53, 113-131.
131. Winsberg, B. G. and Comings, D. E. (1999) Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J. Am. Acad. Child. Adolesc. Psychiatry 38(12), 1474-1477.
132. Xu, C.; Schachar, R.; Tannock, R.; Roberts, W.; Malone, M.; Kennedy, J. L. aad Barr, C. L. (2001) Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am. J. Med. Genet. Neuropsychiatr. Genet.) 105, 159-162.
133. Yang, L.; Wang, Y. -F.; Li, J. and Faraone, S. V. (2004) Association of Norepinephrine Transporter Gene with Methylphenidate Response. J. Am. Acad. Child. Acolesc. Psychiatry 43(9), 1154-1158.
134. Zhang, X. N.; Ruan, L. M.; Le, Y. P. and Zhang, Y. (2003) Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene. Zhonghua. Yi. Xue. Yi. Chuan. Xue. Za. Zhi. 20, 322-324.
135. Zoroglu, S. S.; Erdal, M. E.; Alasehirli, B.; Erdal, N.; Sivasli, E.; Tutkun, H.; Savas, H. A. and Herken, H. (2002) Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiol. 45(4), 176-181.